SAN

87.36

-5.12%↓

MRK1

116.2

+1%↑

SHL.DE

46.58

-0.98%↓

ARGX

505.8

-1.21%↓

FRE

43.06

+1.25%↑

SAN

87.36

-5.12%↓

MRK1

116.2

+1%↑

SHL.DE

46.58

-0.98%↓

ARGX

505.8

-1.21%↓

FRE

43.06

+1.25%↑

SAN

87.36

-5.12%↓

MRK1

116.2

+1%↑

SHL.DE

46.58

-0.98%↓

ARGX

505.8

-1.21%↓

FRE

43.06

+1.25%↑

SAN

87.36

-5.12%↓

MRK1

116.2

+1%↑

SHL.DE

46.58

-0.98%↓

ARGX

505.8

-1.21%↓

FRE

43.06

+1.25%↑

SAN

87.36

-5.12%↓

MRK1

116.2

+1%↑

SHL.DE

46.58

-0.98%↓

ARGX

505.8

-1.21%↓

FRE

43.06

+1.25%↑

Search

Orion Oyj (Class B)

Cerrado

58.7 1.29

Resumen

Variación precio

24h

Actual

Mínimo

58.6

Máximo

58.8

Métricas clave

By Trading Economics

Ingresos

-12M

61M

Ventas

-80M

355M

P/B

Media del Sector

23.508

53.54

BPA

0.44

Rentabilidad por dividendo

2.81

Margen de beneficio

17.287

Empleados

3,943

EBITDA

136M

202M

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

2.81%

2.44%

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

2.7B

8.2B

Apertura anterior

57.41

Cierre anterior

58.7

Orion Oyj (Class B) Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

31 may 2025, 10:30 UTC

Principales Noticias

Pension Funds Won't Save the Bond Market -- Heard on the Street -- WSJ

31 may 2025, 06:30 UTC

Ganancias

5 Things We've Learned From Retail Earnings -- Barrons.com

31 may 2025, 04:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

30 may 2025, 23:51 UTC

Adquisiciones, fusiones, absorciones

Trump Raises Steel Tariffs, Saying U.S. Steel Will Remain U.S.-Controlled -- Update

30 may 2025, 21:30 UTC

Principales Noticias

Stocks Shrug Off Trade War to Post Best Month Since 2023 -- WSJ

30 may 2025, 21:15 UTC

Principales Noticias

The Score: E.l.f. Beauty, Tesla, Nvidia, and More Stocks That Defined the Week -- WSJ

30 may 2025, 20:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Health Care Roundup: Market Talk

30 may 2025, 20:44 UTC

Adquisiciones, fusiones, absorciones

Bill Ackman Is Killing It. A New ETF Will Track His Investments. -- Barrons.com

30 may 2025, 20:24 UTC

Principales Noticias

Major U.S. Stock Indexes Finish About Flat; U.S.-China Trade Friction Renews -- WSJ

30 may 2025, 20:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

30 may 2025, 19:44 UTC

Charlas de Mercado

Gold Breaks 4-Month Winning Streak -- Market Talk

30 may 2025, 19:38 UTC

Charlas de Mercado

Companies Delay or Cancel $14B In Clean-Energy Investments -- Market Talk

30 may 2025, 19:29 UTC

Ganancias
Adquisiciones, fusiones, absorciones

NRG Energy and UnitedHealth Are the S&P 500's Best and Worst for May. Here's Why. -- Barrons.com

30 may 2025, 19:14 UTC

Charlas de Mercado

Oil Settles Lower Ahead of OPEC+ Output Decision -- Market Talk

30 may 2025, 19:05 UTC

Charlas de Mercado

U.S. Natural Gas Futures Fall Awaiting Hotter Weather -- Market Talk

30 may 2025, 18:51 UTC

Charlas de Mercado

Canada's Retaliatory Tariffs Help Fuel Sizable Rise in Tax Revenue -- Market Talk

30 may 2025, 18:37 UTC

Charlas de Mercado
Ganancias

Costco Well Positioned for Sustainable Growth, UBS Says -- Market Talk

30 may 2025, 18:04 UTC

Principales Noticias

S&P 500 Falls After More Trump-China Friction -- WSJ

30 may 2025, 17:47 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

30 may 2025, 17:47 UTC

Charlas de Mercado

Time for BoC Gov. Macklem to Cut Rates, Desjardins Says -- Market Talk

30 may 2025, 17:40 UTC

Adquisiciones, fusiones, absorciones

Trump Is Praising His U.S. Steel Deal. No One Is Sure What It Means -- WSJ

30 may 2025, 17:38 UTC

Charlas de Mercado

U.S: Oil Rig Count Falls for Fifth Straight Week -- Market Talk

30 may 2025, 17:31 UTC

Charlas de Mercado

Costco Well Positioned to Gain Share Amid Tariffs, Baird Says -- Market Talk

30 may 2025, 17:14 UTC

Principales Noticias

American Consumers Are Still Gloomy on the Economy -- 3rd Update

30 may 2025, 16:31 UTC

Ganancias

Ulta Beauty Stock Is Rising. Earnings Strength Was More Than Cosmetic. -- Barrons.com

30 may 2025, 16:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

30 may 2025, 16:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Health Care Roundup: Market Talk

30 may 2025, 16:16 UTC

Principales Noticias

S&P 500 Falls After Trump Hits Out at China -- WSJ

30 may 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

30 may 2025, 16:14 UTC

Principales Noticias

HSBC Retreats From Banking Smaller U.S. Businesses -- WSJ

Comparación entre iguales

Cambio de precio

Orion Oyj (Class B) Esperado

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Orion Oyj (Class B)

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. It has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; collaboration and option to license agreement with Abilita Therapeutics to develop innovative antibody therapeutics; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.